Drug profile · INN
levalbuterol hydrochloride
LEVALBUTEROL HYDROCHLORIDE
levalbuterol hydrochloride (LEVALBUTEROL HYDROCHLORIDE) is a beta-2 adrenergic receptor agonist. Associated with Teva Pharma GmbH. Route of administration: inhalation. Current US regulatory status: approved.
Drug details — levalbuterol hydrochloride
- US status
- approved
- Class
- —
- Route
- INHALATION
- Patents
- 2
- Programs
- 0
- Data quality
- 0.89
Quick answer
levalbuterol hydrochloride (LEVALBUTEROL HYDROCHLORIDE) is a beta-2 adrenergic receptor agonist. Associated with Teva Pharma GmbH. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-2 adrenergic receptor agonist
Primary target: Beta-2 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
Frequently asked questions
What is levalbuterol hydrochloride?
levalbuterol hydrochloride (LEVALBUTEROL HYDROCHLORIDE) is a beta-2 adrenergic receptor agonist. Associated with Teva Pharma GmbH. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for levalbuterol hydrochloride?
LEVALBUTEROL HYDROCHLORIDE is a marketed brand name for levalbuterol hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of levalbuterol hydrochloride?
levalbuterol hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.